- Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation
Milad Ashrafizadeh et al, 2024, Cancer and Metastasis Reviews CrossRef - Involvement of HMGB1 in vemurafenib resistance in thyroid cancer cells harboring BRAF (V600E) mutation by regulating excessive autophagy
Lin Run et al, 2021, Endocrine CrossRef - High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics
Eyaldeva C. Vijayakumar et al, 2019, Current Drug Targets CrossRef